The FMCG major reported a consolidated net profit of ₹652 crore, up 27% from ₹513 crore a year ago, surpassing the CNBC-TV18 poll estimate of ₹587 crore. Revenue rose 23% year-on-year to ₹3,957 crore from ₹3,221 crore in the corresponding quarter last year, also ahead of the CNBC-TV18 estimate of ₹3,927 crore.
Earnings before interest, tax, depreciation and amortisation (EBITDA) increased 25% to ₹819 crore from ₹655 crore a year earlier, compared with the CNBC-TV18 poll estimate of ₹776 crore. EBITDA margin expanded to 20.7% from 20.1% in the year-ago quarter, higher than the poll estimate of 19.8%.
Profit before tax rose to ₹790 crore from ₹656 crore a year earlier, while total expenses increased to ₹3,215 crore from ₹2,621 crore.
Cost of materials consumed rose to ₹1,751 crore from ₹1,184 crore, while employee benefit expenses increased to ₹269 crore from ₹220 crore. Advertisement and sales promotion expenses also rose to ₹288 crore from ₹261 crore, while finance costs increased to ₹21 crore from ₹10 crore.
During the quarter, Marico completed the acquisition of a 75% stake in Vietnam-based Skinetiq Joint Stock Company through its wholly owned subsidiary, Marico South East Asia Corporation.
Skinetiq owns the digital-first skincare brand Candid and holds exclusive distribution rights for luxury skincare brand Murad in Vietnam. The company said the June quarter results include the impact of this acquisition from April 2, 2026, making them not directly comparable with previous periods.
The company also completed the integration of the businesses of Just Herbs and Beardo into Marico following the voluntary liquidation of their respective wholly owned subsidiaries. Marico said these intra-group restructurings have no impact on the group’s consolidated financial results.Separately, Marico reclassified certain customer-related advertisement and promotional expenses by netting them off against revenue from operations as a change in accounting policy.
The company said the retrospective reclassification does not impact profit before tax, profit after tax, earnings per share or shareholders’ equity.
Shares of the company ended 0.68% lower at ₹875 ahead of the results announcement on Tuesday. The stock has gained 15% so far in 2026 and about 21% over the 12 months.
Also read: Nazara board to consider fundraise, founder Nitish Mittersain steps down as CEO
